Evidence map›Paper›PMID 36615053›Full record

ArticleJournal of clinical medicine2022

Role of Radiomics Features and Machine Learning for the Histological Classification of Stage I and Stage II NSCLC at [

Francesco Dondi, Roberto Gatta, Domenico Albano, Pietro Bellini, Luca Camoni, Giorgio Treglia, Francesco Bertagna

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Correlation ofScientific reports · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. [18F]FDG- PET/CT in Staging and Restaging of Fetal Type Adenocarcinoma of the Lung: A Case Report and a Review of the Literature.Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Francesco DondiNuclear Medicine, ASST Spedali Civili Brescia, 25123 Brescia, Italy.ORCID 0000-0003-4839-9033
Roberto GattaDipartimento di Scienze Cliniche e Sperimentali, Università degli Studi di Brescia, 25123 Brescia, Italy.ORCID 0000-0002-4716-9925
Domenico AlbanoNuclear Medicine, Università degli Studi di Brescia and ASST Spedali Civili Brescia, 25123 Brescia, Italy.ORCID 0000-0003-0810-6494
Pietro BelliniNuclear Medicine, Università degli Studi di Brescia and ASST Spedali Civili Brescia, 25123 Brescia, Italy.
Luca CamoniNuclear Medicine, ASST Spedali Civili Brescia, 25123 Brescia, Italy.ORCID 0000-0003-1654-323X
Giorgio TregliaNuclear Medicine, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland.ORCID 0000-0001-9808-780X
Francesco BertagnaNuclear Medicine, Università degli Studi di Brescia and ASST Spedali Civili Brescia, 25123 Brescia, Italy.
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · ITEnte Ospedaliero Cantonale · CHUniversity of Brescia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to compare two different PET/CT tomographs for the evaluation of the role of radiomics features (RaF) and machine learning (ML) in the prediction of the histological classification of stage I and II non-small-cell lung cancer (NSCLC) at baseline [

Indexed as

FDGlung cancermachine learningPET/CTradiomicstexture analysis

Identifiers

PMID36615053
PMCPMC9820870
OpenAlexW4313327956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.